Scott H. Donaldson
Co-Principal Investigator
Credentials: · · ·
History
Research
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation
New England Journal of Medicine · 2010 · 629 citations
Mucus clearance and lung function in cystic fibrosis with hypertonic saline
New England Journal of Medicine · 2006 · First of 6 authors · Corresponding · 529 citations
American Journal of Respiratory and Critical Care Medicine · 2014 · 428 citations
20 papers
19 papers
- JC
16 papers
13 papers
10 papers
9 papers
- DN
8 papers
- DG
7 papers
Grants
- 2003–2030
UNC Cystic Fibrosis Research and Translation Core Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $2.5M · Univ of North Carolina Chapel Hill
- 2017–2024
Development of Novel Mycolytic Therapies for Lung Disease
National Heart, Lung, and Blood Institute · P01
Project lead · $3.2M · Univ of North Carolina Chapel Hill
- 2006–2011
SCCOR in Host Factors in Chronic Lung Disease
National Heart, Lung, and Blood Institute · P50
Project lead · $1.8M · Univ of North Carolina Chapel Hill
- 2003–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $80.8K · Univ of North Carolina Chapel Hill
Clinical trials
- 2024–2029
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Principal investigator · Recruiting
Nicole Hamblett
- 2017–2018
Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2017–2018
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2016
Principal investigator · Withdrawn
University of North Carolina, Chapel Hill